REducing With MetfOrmin Vascular Adverse Lesions in Type 1 Diabetes (REMOVAL)

PHASE3CompletedINTERVENTIONAL
Enrollment

493

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

March 19, 2017

Study Completion Date

April 18, 2017

Conditions
Diabetes Mellitus, Type 1
Interventions
DRUG

Metformin

3 years treatment duration

DRUG

Placebo

3 years duration

Trial Locations (24)

Unknown

Royal Melbourne Hospital, Melbourne

St Vincent's Hospital, Melbourne

Royal Prince Albert Hospital, Sydney

St Joseph's Health Care, London

Ottawa Hospital Riverside Campus, Ottawa

Steno Diabetes Centre, Gentofte Municipality

Maastricht University Medical Centre, Maastricht

Aberdeen Royal Infirmary, Aberdeen

Diabetes Support Unit, Ninewells Hospital and Medical School, Dundee

University Hospital North Durham, Durham

Edinburgh Royal Infirmary, Edinburgh

Edinburgh Western Infirmary, Edinburgh

Peninsula NIHR Clinical Research Facility, Royal Devon and Exeter NHS Foundation Trust, Exeter

Stobhill Hospital, Diabetes Clinic, Glasgow

Michael White Diabetes Centre, Hull Royal Infirmary, Hull

Clinical Sciences Centre, University Hospital, Liverpool

Clinical Investigation Unit, International Centre for Circulatory Health, Imperial College Healthcare NHS Trust, London

Wellcome Trust Clinical Research Facility, Manchester Royal Infirmary, Manchester

Newcastle NIHR Clinical Research Facility, Royal Victoria Hospital, Newcastle

Diabetes Clinical Research Centre, Plymouth, Plymouth

Salford Royal NHS Foundation Trust, Salford

KA6 6DX

Ayr Hospital, Ayr

BS2 8HW

University Hospitals Bristol, Bristol

GL1 3NN

Gloucestershire Royal Hospital, Gloucester

All Listed Sponsors
collaborator

NHS Greater Glasgow and Clyde

OTHER

collaborator

Juvenile Diabetes Research Foundation

OTHER

collaborator

Imperial College London

OTHER

collaborator

University of Wisconsin, Madison

OTHER

collaborator

University of Dundee

OTHER

collaborator

Merck Serono S.A., Geneva

INDUSTRY

collaborator

Itamar-Medical, Israel

INDUSTRY

collaborator

University of Western Ontario, Canada

OTHER

collaborator

University of Melbourne

OTHER

collaborator

Steno Diabetes Center Copenhagen

OTHER

collaborator

Maastricht University Medical Center

OTHER

lead

University of Glasgow

OTHER